Supramolecular Mimotope Peptide Nanofibers Promote Antibody–Ligand Polyvalent and Instantaneous Recognition for Biopharmaceutical Analysis
Analytical Chemistry · 2024
DOI: 10.1021/acs.analchem.4c00051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2024. Verfasst von Qiaoxian He und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Analysis, College of Pharmacy/State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Coope…. Hauptthemen laut MEDLINE: Biological Products, Nanofibers. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: High-end Foreign Experts Recruitment Plan of China, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Peptide-based supramolecules exhibit great potential in various fields due to their improved target recognition ability and versatile functions. However, they still suffer from numerous challenges for the biopharmaceutical analysis, including poor self-assembly ability, undesirable ligand-antibody binding rates, and formidable target binding barriers caused by ligand crowding. To tackle these issues, a "polyvalent recognition" strategy employing the CD20 mimotope peptide derivative NBD-FFVLR-GS-WPRWLEN (acting on the CDR domains of rituximab) was proposed to develop supramolecular nanofibers for target antibody recognition. These nanofibers exhibited rapid self-assembly within only 1 min and robust stability. Their binding affinity (179 nM) for rituximab surpassed that of the monomeric peptide (7 μM) by over 38-fold, highlighting that high ligand density and potential polyvalent recognition can efficiently overcome the target binding barriers of traditional supramolecules. Moreover, these nanofibers exhibited an amazing "instantaneous capture" rate (within 15 s), a high recovery (93 ± 3%), and good specificity for the target antibody. High-efficiency enrichment of rituximab was achieved from cell culture medium with good recovery and reproducibility. Intriguingly, these peptide nanofibers combined with bottom-up proteomics were successful in tracking the deamidation of asparagine 55 (from 10 to 16%) on the rituximab heavy chain after 21 day incubation in human serum. In summary, this study may open up an avenue for the development of versatile mimotope peptide supramolecules for biorecognition and bioanalysis of biopharmaceuticals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Analysis, College of Pharmacy/State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and In…
- Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, P. R. China.
- School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
- Laboratory for the Analysis of Medicines, Department of Pharmaceutical Sciences, CIRM, University of Liege, CHU B36, B-4000 Liege, Belgium.
- School of Science, Harbin Institute of Technology, Shenzhen, Guangdong 518055, China.
ORCID-Profile: Marianne Fillet, Yingchun Li, Zhengjin Jiang
Förderung
- High-end Foreign Experts Recruitment Plan of China
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Guangdong Provincial Medical Products Administration, China
Zitieren
APA
He, Q., Chen, F., Zhao, Z., Pei, P., Gan, Y., Zhou, A., Zhou, J., Qu, J. H., Crommen, J., Fillet, M., Li, Y., Wang, Q., & Jiang, Z. (2024). Supramolecular Mimotope Peptide Nanofibers Promote Antibody–Ligand Polyvalent and Instantaneous Recognition for Biopharmaceutical Analysis. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c00051
Vancouver
He Q, Chen F, Zhao Z, Pei P, Gan Y, Zhou A, et al. Supramolecular Mimotope Peptide Nanofibers Promote Antibody–Ligand Polyvalent and Instantaneous Recognition for Biopharmaceutical Analysis. Analytical Chemistry. 2024. doi:10.1021/acs.analchem.4c00051
BibTeX
@article{He2024,
author = {He, Qiaoxian and Chen, Feng and Zhao, Zheng and Pei, Pengfei and Gan, Yongqing and Zhou, Aixuan and Zhou, Jingwei and Qu, Jia-Huan and Crommen, Jacques and Fillet, Marianne and Li, Yingchun and Wang, Qiqin and Jiang, Zhengjin},
title = {Supramolecular Mimotope Peptide Nanofibers Promote Antibody–Ligand Polyvalent and Instantaneous Recognition for Biopharmaceutical Analysis},
journal = {Analytical Chemistry},
year = {2024},
doi = {10.1021/acs.analchem.4c00051}
}
EUVIMED